How Trump’s Choice to Lead FDA Aligns With RFK Jr.’s Views on Health and Transparency

Dr. Marty Makary, President-elect Donald Trump’s choice to lead the Food and Drug Administration (FDA), and Robert F. Kennedy Jr., his nominee to head the Department of Health and Human Services (HHS), are both critics of COVID-19 mandates, advocates for removing chemicals and toxins from America’s food supply, and proponents of greater transparency in medicine.
If both men are confirmed by the Senate in January 2025, Kennedy will serve as Makary’s boss, as the FDA is one of 13 agencies under HHS.
Makary, a professor and surgeon at Johns Hopkins University, has also criticized the use of pesticides on food, the overprescription of drugs, and the influence of insurance and pharmaceutical companies over physicians and government agencies, issues that Kennedy has been highlighting for years….